Francesco Sinigaglia becomes Chairman at Eyevensys Francesco Sinigaglia becomes Chairman at Eyevensys Raffy Kazandjian is Chief Executive at the French ophthalmic company Crown Bioscience strengthens pre-clinical leadership team Crown Bioscience strengthens pre-clinical leadership team Hires Laurie Heilmann as Senior Vice President Global Strategy, Marketing Business Development Heptares scientists receive 2015 Malcolm Campbell Memorial Prize Heptares scientists receive 2015 Malcolm Campbell Memorial Prize In recognition of their contribution to GPCR drug discovery Mark Sawicki joins Cryoport as Chief Commercial Officer Mark Sawicki joins Cryoport as Chief Commercial Officer Will lead the sales and marketing team at the cryogenic logistics solutions company Medivir makes changes to management team Medivir makes changes to management team To create a smaller and more effective team with fewer functions ABPI appoints Dr Virginia Acha as Research Medical and Innovation Director ABPI appoints Dr Virginia Acha as Research Medical and Innovation Director She takes up the position at the beginning of March Cornelius Group Board reorganises for growth Cornelius Group Board reorganises for growth Darren Spiby takes responsibility for the overall UK and international business Domino makes three promotions Domino makes three promotions Three members of the coding and marking company take up more senior sales roles Promethera Biosciences sees departure of CEO Eric Halioua Promethera Biosciences sees departure of CEO Eric Halioua The recruitment process to find his successor is underway XenoGesis appoints Director of External Projects XenoGesis appoints Director of External Projects Graham Trevitt joins the Nottingham, UK-based contract research organisation Paul Thomas joins Aegate as Regional Business Development Manager UK & Ireland Paul Thomas joins Aegate as Regional Business Development Manager UK & Ireland Formerly Head of Sales at Novo Nordisk New Vice-Chair appointed to Commission on Human Medicines New Vice-Chair appointed to Commission on Human Medicines Dr Angela Thomas replaces Professor Ian Weller Mission Therapeutics appoints Anker Lundemose as Chief Executive Mission Therapeutics appoints Anker Lundemose as Chief Executive UK company is in the transition stage from discovery to development of treatments for cancer Denny Bros restructures Board of Directors Denny Bros restructures Board of Directors Barry Denny becomes Chairman, while Graham Denny steps up to Managing Director Endo announces changes to senior management team Endo announces changes to senior management team To accelerate growth both organically and through corporate development activities Ken Dickerson joins BiOptix as Vice President of Sales Ken Dickerson joins BiOptix as Vice President of Sales Brings 20 years of experiences in sales to his new position Vaccinogen names Peter Morsing as Head of Business Development Vaccinogen names Peter Morsing as Head of Business Development Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company Cytovance Biologics appoints Director of Purification Development Cytovance Biologics appoints Director of Purification Development Seth Fisher joins the team in Oklahoma City, US CiToxLAB hires Senior Director of Biomarkers CiToxLAB hires Senior Director of Biomarkers Philippe Ancian returns to the French contract research organisation Marken appoints General Manager for Argentina and Brazil Marken appoints General Manager for Argentina and Brazil Antonio Beloto will lead logistical operations in both countries Hovione promotes Filipe Gaspar to Vice President of Research & Development Hovione promotes Filipe Gaspar to Vice President of Research & Development He joined the Portuguese company in 2003 Associate Partner joins Alacrita in Cambridge, MA, US Associate Partner joins Alacrita in Cambridge, MA, US William Slichenmyer will advise on clinical development strategy, planning and operations New Chief Innovation Officer at Evonik New Chief Innovation Officer at Evonik Ulrich Kuesthardt succeeds Peter Nagler Rx-360 announces new officers and changes to board Rx-360 announces new officers and changes to board The new officers will each serve a two-year term